AVBP
ArriVent BioPharma, Inc. Common Stock ·
—
Market cap
—
52-week range
—
Volume
—
Previous close
—
ArriVent BioPharma, Inc. Common Stock (AVBP) is held by 3 tracked hedge fund(s). Largest tracked holder: Suvretta Capital.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| Suvretta Capital Aaron Cowen |
2.6% | 4.4M | $102M | ▲ 7.2% (+295K) | $20.42 | 2026-03-31 |
| HHLR Advisors Hillhouse |
5.4% | 3.9M | $91M | — | $17.95 | 2026-03-31 |
| ORBIMED ADVISORS LLC ORBIMED ADVISORS LLC |
1.4% | 3.0M | $70M | — | $17.86 | 2026-03-31 |
FAQ ▾
Which hedge funds hold AVBP?
Tracked holders include: Suvretta Capital, HHLR Advisors, ORBIMED ADVISORS LLC.
How much smart money owns AVBP?
3 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading AVBP?
No tracked Congressional trades in AVBP on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.